In Group II, the most prevalent MSA-Non-ARS was anti-Mi-2α/β (16.87%), with the associated MAAs being PM-Scl-75/100 (38.09%) and Ro-52 (36.11%). The gene discussed is CHD3; the disease is Axenfeld-Rieger syndrome.